MTD vs PTHS · P/E 27, rev $1.97B vs rev $16.8M
Mettler-Toledo International Inc (MTD) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the MTD and PTHS stock pages for the full models.
Not investment advice.